MYCN and neuroblastoma: On the other hand, some molecular alterations associated with neurological tumors have already been detected in plasma cfDNA, such as the number of MYCN copies in neuroblastoma [88] or specific somatic mutations in glioblastoma (EGFR [89] and IDH1 [90]).